Searched over 200M research papers for "nad suppliments"
10 papers analyzed
These studies suggest NAD supplementation may have benefits for aging, metabolic health, and specific diseases like psoriasis, neurodegenerative disorders, and heart failure, but further research is needed to confirm optimal methods and target conditions.
20 papers analyzed
Nicotinamide adenine dinucleotide (NAD) is a crucial coenzyme found in all living cells, playing a significant role in redox reactions, metabolism, and cellular repair processes. NAD exists in two forms: NAD+ (oxidized) and NADH (reduced), both of which are essential for mitochondrial function and energy production. As we age, NAD+ levels decline, contributing to various age-related diseases and metabolic dysfunctions .
Nicotinamide riboside (NR) is a natural NAD+ precursor that has shown promise in enhancing oxidative metabolism and protecting against metabolic diseases. Studies have demonstrated that NR supplementation increases NAD+ levels, activates sirtuins (SIRT1 and SIRT3), and improves metabolic health, particularly in the context of high-fat diet-induced obesity. Additionally, NR has been found to ameliorate age-associated pathologies and improve mitochondrial function .
Nicotinamide mononucleotide (NMN) is another NAD+ precursor that has been extensively studied for its therapeutic potential. NMN supplementation has shown preventive and therapeutic effects on age-related diseases, including neurodegenerative conditions and metabolic disorders . Notably, NMN has been found to rejuvenate oocyte quality and restore fertility in aged female mammals, highlighting its potential in reproductive health.
Research indicates that NAD+ supplementation can counteract many age-associated functional defects. For instance, increasing NAD+ levels through supplementation has been shown to improve neurodegenerative diseases, enhance skeletal muscle activity, and potentially treat conditions like psoriasis . However, more clinical trials are needed to determine the optimal methods for raising NAD+ levels and to compare these methods with existing treatments.
NAD+ plays a critical role in regulating metabolism and circadian rhythms. Supplementation with NAD+ precursors has been shown to protect against metabolic diseases, such as obesity and diabetes, by enhancing mitochondrial function and oxidative metabolism . Furthermore, NAD+ replenishment has been found to extend healthspan and reduce blood pressure in preclinical models, suggesting its potential in preventing cardiovascular diseases.
Emerging evidence suggests that NAD+ supplementation can improve cardiac function and bioenergetics in heart failure models. Studies have shown that increasing NAD+ levels can reduce cardiac dysfunction and improve outcomes in various heart conditions, including atherosclerosis and hypertrophic cardiomyopathy . These findings underscore the potential of NAD+ precursors as therapeutic agents for cardiovascular diseases.
NAD+ supplementation, particularly through precursors like NR and NMN, holds significant promise for treating a range of age-related and metabolic conditions. While preclinical studies and limited clinical trials have shown encouraging results, further research is necessary to establish the most effective methods for NAD+ upregulation and to validate these findings in larger, well-powered clinical trials. The potential benefits of NAD+ supplementation in enhancing healthspan and treating age-associated diseases make it a compelling area of ongoing research.
Most relevant research papers on this topic